IP Library Granted Patent US 9,480,824
Granted Patent B2
US 9,480,824 · App. 14/139,609 · Granted Nov 1, 2016

Cuff-resistant anchoring balloon for medical device

Inventors: Christopher Charles Kaiser (Holliston, MA); Jessica Tina Schenck (Shrewsbury, MA)
Assignee: Hologic, Inc.
A61M25/1002A61M25/0017A61M25/04A61M25/1027A61M25/1029A61B2018/00279A61B2018/00285A61M25/1006A61M25/1011A61M25/1025A61M25/1034A61M25/1036A61M2025/1043A61M2025/1059A61M2025/1061A61M2025/1068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,480,824
App. No.
14/139,609
Granted
Nov 1, 2016
Kind
B2
Abstract

A medical device having an elongate support structure and an inflatable balloon including a first-end portion secured to the support structure at a first location, a second-end portion secured to the support structure at a second location distal to the first location, and a middle-body portion. The first-end portion has a wall thickness greater than a wall thickness of the middle-body portion; the balloon defines a sealed interior through which the support structure extends. The balloon being stretch-mounted to the support structure in tension relative to the support structure; the balloon is formed in a diamond-like configuration that transitions to a substantially spherical configuration when the balloon is inflated to a inflation pressure that is at least about ten percent greater than atmospheric pressure, such that when inflated to the inflation pressure and anchored in an anatomical body region, resists movement of the support structure relative to the balloon.

Claims (30)

1. A medical device, comprising:

an elongate support structure; and

an inflatable balloon, the balloon comprising a first-end portion secured to the support structure at a first location, a second-end portion secured to the support structure at a second location distal to the first location, and a middle-body portion,

the middle-body portion having a first end integrally formed with or otherwise bonded to the first-end portion, and a second end integrally formed with or otherwise bonded to the second-end portion,

the first-end portion having a wall thickness greater than a wall thickness of the middle-body portion,

the respective first-end portion, middle-body portion and second-end portion collectively defining a sealed interior of the balloon through which the support structure extends,

the balloon being stretch-mounted to the support structure so as to be in tension relative to the support structure,

wherein the balloon is formed in a diamond shaped configuration that transitions to a substantially spherical configuration when the balloon is inflated to an inflation pressure that is at least about ten percent greater than atmospheric pressure external to the balloon,

such that the balloon, when inflated to the inflation pressure and anchored in an anatomical body region, resists movement of the support structure relative to the balloon.

2. The medical device of claim 1 , wherein the balloon middle-body portion is twisted relative to the support structure.

3. The medical device of claim 1 , wherein the support structure comprises a plurality of elongate members, and wherein the first-end portion of the balloon is secured to a first elongate member of the support structure, and the second-end portion of the balloon is secured to a second elongate member of the support structure.

4. The medical device of claim 1 , wherein the first-end portion and second-end portion of the balloon are each secured to the support structure by one of adhesive bonding, thermal bonding, interlocking geometries, and mechanical fastening.

5. The medical device of claim 1 , wherein the balloon comprises one or more polymeric materials.

6. The medical device of claim 5 , wherein the balloon comprises a shore durometer in a range of between about A90 to about A100.

7. The medical device of claim 5 , wherein the balloon comprises a shore durometer in a range of between about D30 to about D70.

8. The medical device of claim 1 , wherein the balloon, when inflated to the inflation pressure, resists cuffing relative to the support structure.

9. The medical device of claim 1 , wherein the inflation pressure is at least about 12 percent greater than the atmospheric pressure.

10. The medical device of claim 1 , wherein the balloon middle-body portion has a non-tensioned length, and wherein the balloon middle-body portion is stretched to a tensioned length that is in a range of about 8% to about 12% greater than the non-tensioned length.

11. A method of manufacturing a medical device, comprising:

forming an inflatable balloon having a first-end portion, a second-end portion, and a middle-body portion, the middle-body portion having a first end integrally formed with or otherwise bonded to the first-end portion, and a second end integrally formed with or otherwise bonded to the second-end portion, the first-end portion having a wall thickness greater than a wall thickness of the middle-body portion;

securing the first-end portion of the balloon to a first location on an elongate support structure; and

securing the second-end portion of the balloon to a second location distal to the first location on the elongate support structure, the first and second locations being spaced apart such that the balloon is stretch-mounted to the support structure so as to be in tension relative to the support structure, the first-end portion, middle-body portion and second-end portion of the balloon collectively define a sealed interior of the balloon through which the support structure extends,

wherein the balloon is formed in a diamond shaped configuration that transitions to a substantially spherical configuration when the balloon is inflated to an inflation pressure that is at least about ten percent greater than atmospheric pressure external to the balloon.

12. The method of claim 11 , wherein the middle-body portion of the balloon is twisted relative to the support structure prior to securing the second-end portion of the balloon to the support structure.

13. The method of claim 11 , wherein the support structure comprises a plurality of elongate members, and wherein the first-end portion of the balloon is secured to a first elongate member of the support structure, and the second-end portion of the balloon is secured to a second elongate member of the support structure.

14. The method of claim 11 , wherein the first-end portion and second-end portion of the balloon are each secured to the support structure by one of adhesive bonding, thermal bonding, interlocking geometries, and mechanical fastening.

15. The method of claim 11 , wherein the balloon comprises one or more polymeric materials.

16. The method of claim 15 , wherein the balloon comprises a shore durometer in a range of between about A90 to about A100.

17. The method of claim 15 , wherein the balloon comprises a shore durometer in a range of between about D30 to about D70.

18. The method of claim 11 , wherein the balloon middle-body portion has a non-tensioned length, and wherein the balloon middle-body portion is stretched to a tensioned length that is in a range of about 8% to about 12% greater than the non-tensioned length.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 032059 0467 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036126/0813 →
SECURITY AGREEMENT Recorded Jan 16, 2014
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 032059/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2014
From: KAISER, CHRISTOPHER CHARLES; SCHENCK, JESSICA TINA
To: HOLOGIC, INC.
Reel/Frame 031953/0375 →
Continuity (1)
Related Publication 20150174380A1 · Jun 25, 2015